APA (7th ed.) Citation

EK, G., O, S., H, A., F, P., AP, Z. Y., F, A., & M, A. (2026). The potential role of daraxonrasib (RMC-6236) in relapsed neuroblastoma patients and the urgent need for preclinical investigations. Journal of pediatric surgery, 163278. https://doi.org/10.1016/j.jpedsurg.2026.163278

Chicago Style (17th ed.) Citation

EK, Gungormez, Sair O, Aydogdu H, Pederiva F, Zorba Yildiz AP, Asir F, and Azizoglu M. "The Potential Role of Daraxonrasib (RMC-6236) in Relapsed Neuroblastoma Patients and the Urgent Need for Preclinical Investigations." Journal of Pediatric Surgery 2026: 163278. https://doi.org/10.1016/j.jpedsurg.2026.163278.

MLA (9th ed.) Citation

EK, Gungormez, et al. "The Potential Role of Daraxonrasib (RMC-6236) in Relapsed Neuroblastoma Patients and the Urgent Need for Preclinical Investigations." Journal of Pediatric Surgery, 2026, p. 163278, https://doi.org/10.1016/j.jpedsurg.2026.163278.